| IN FOCUS |
|
| Year : 2007 | Volume
: 13
| Issue : 3 | Page : 147-149 |
|
|
Fibroscan® : A noninvasive test of liver fibrosis assessment
Abdullah S Al-Ghamdi
Gastroenterology Division, Medical Department, King Fahad General Hospital, PO Box 50564, Jeddah 21533, Saudi Arabia
Correspondence Address:
Abdullah S Al-Ghamdi
Gastroenterology Division, Medical Department, King Fahad General Hospital, PO Box 50564, Jeddah 21533
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-3767.33470
|
|
|
Determination of the extent of progress of hepatic fibrosis is important in clinical practice, where it may reflect the severity of liver disease and predict response to treatment. Percutaneous liver biopsy is the gold standard for grading and staging of liver disease. However, liver biopsy is an invasive procedure with certain unavoidable risks and complications. Several methods have been studied in an attempt to reach a diagnosis of cirrhosis by noninvasive means. Fibroscan® has been designed to quantify liver fibrosis by means of elastography and found to have reasonably good sensitivity and specificity patterns, especially in patients with advanced fibrosis and can be used as an alternative to liver biopsy. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
